D.E. Shaw & Co
LFST icon

D.E. Shaw & Co’s Lifestance Health LFST Stock Holding History

D.E. Shaw & Co’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91M Sell
551,831
-92,321
-14% -$714K ﹤0.01% 2265
2026
Q1 		$4.1M Buy
644,152
+505,200
+364% +$3.52M ﹤0.01% 2328
2025
Q4 		$978K Buy
138,952
+123,859
+821% +$747K ﹤0.01% 3562
2025
Q3 		$83K Sell
15,093
-315,433
-95% -$1.55M ﹤0.01% 4370
2025
Q2 		$1.71M Sell
330,526
-122,408
-27% -$733K ﹤0.01% 2855
2025
Q1 		$3.02M Buy
452,934
+391,687
+640% +$2.98M ﹤0.01% 2301
2024
Q4 		$451K Buy
+61,247
New +$440K ﹤0.01% 3679
2022
Q3 		– Sell
-27,787
Closed -$154K – 5365
2022
Q2 		$154K Sell
27,787
-120,854
-81% -$926K ﹤0.01% 4629
2022
Q1 		$1.5M Buy
+148,641
New +$1.3M ﹤0.01% 3574

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

D.E. Shaw & Co's LFST Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Lifestance Health (LFST) stake by 14% in Q2 2026, selling an estimated $714K and leaving 551,831 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2265.

D.E. Shaw & Co first reported a position in LFST in Q1 2022 and has held it in 9 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • D.E. Shaw & Co held 551,831 shares of Lifestance Health worth $5.91M as of Q2 2026.
  • D.E. Shaw & Co sold 92,321 Lifestance Health shares in Q2 2026, an estimated $714K.
  • Lifestance Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2265 holding.
  • D.E. Shaw & Co first reported a position in Lifestance Health in Q1 2022 and has held it in 9 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.